Utility of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies: a viewpoint from the FDA

被引：0
|
作者：
Penzenstadler, Justin [1 ]
Earp, Justin C. [2 ]
Heickman, Lauren K. Wood K. [1 ]
Pluchino, Kristen [1 ]
机构：
[1] US FDA, Ctr Drug Evaluat & Res, Div Diabet & Lipid Disorders Obesity, Silver Spring, MD 20740 USA
[2] US FDA, Ctr Drug Evaluat & Res, Div Pharmacometr, Silver Spring, MD USA
来源：
DIABETOLOGIA | 2023年 / 66卷 / 03期
关键词：
D O I：
10.1007/s00125-022-05853-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：603 / 604
页数：2
相关论文
共 50 条
  • [41] Islet autoantibodies in type-1 or type-2 diabetes in four US racial groups
    Marker, JD
    Chopra, M
    Ten, S
    Su, K
    Zeidler, A
    Raskin, P
    Rappaport, R
    Schatz, D
    Vargas, A
    Malone, J
    Bode, B
    Krischer, J
    MacLaren, NK
    DIABETES, 2001, 50 : A262 - A262
  • [42] Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
    Ng, Kenney
    Anand, Vibha
    Stavropoulos, Harry
    Veijola, Riitta
    Toppari, Jorma
    Maziarz, Marlena
    Lundgren, Markus
    Waugh, Kathy
    Frohnert, Brigitte, I
    Martin, Frank
    Lou, Olivia
    Hagopian, William
    Achenbach, Peter
    DIABETOLOGIA, 2023, 66 (01) : 93 - 104
  • [43] Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes
    Matsumoto, Shinichi
    Abalovich, Adrian
    Wechsler, Carlos
    Wynyard, Shaun
    Elliott, Robert B.
    EBIOMEDICINE, 2016, 12 : 255 - 262
  • [44] Islet transplantation as treatment of type 1 diabetes: from experimental beginnings to clinical application
    Federlin, KF
    Jahr, H
    Bretzel, RG
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 : S373 - S383
  • [45] Slowly progressing type 1 diabetes: Persistence of islet cell autoantibodies is related to glibenclamide treatment
    Cabrera-Rode, E
    Perich, P
    Diaz-Horta, O
    Tiberti, C
    Molina, G
    Arranz, C
    Martin, JM
    Licea, M
    De Leiva, A
    Puig-Domingo, M
    Dimario, U
    AUTOIMMUNITY, 2002, 35 (07) : 469 - 474
  • [46] Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review
    Felton, Jamie L.
    Redondo, Maria J.
    Oram, Richard A.
    Speake, Cate
    Long, S. Alice
    Onengut-Gumuscu, Suna
    Rich, Stephen S.
    Monaco, Gabriela S. F.
    Harris-Kawano, Arianna
    Perez, Dianna
    Saeed, Zeb
    Hoag, Benjamin
    Jain, Rashmi
    Evans-Molina, Carmella
    DiMeglio, Linda A.
    Ismail, Heba M.
    Dabelea, Dana
    Johnson, Randi K.
    Urazbayeva, Marzhan
    Wentworth, John M.
    Grif, Kurt J.
    Sims, Emily K.
    Tobias, Deirdre K.
    Merino, Jordi
    Ahmad, Abrar
    Aiken, Catherine
    Benham, Jamie L.
    Bodhini, Dhanasekaran
    Clark, Amy L.
    Colclough, Kevin
    Corcoy, Rosa
    Cromer, Sara J.
    Duan, Daisy
    Felton, Jamie L.
    Francis, Ellen C.
    Gillard, Pieter
    Gingras, Veronique
    Gaillard, Romy
    Haider, Eram
    Hughes, Alice
    Ikle, Jennifer M.
    Jacobsen, Laura M.
    Kahkoska, Anna R.
    Kettunen, Jarno L. T.
    Kreienkamp, Raymond J.
    Lim, Lee-Ling
    Mannisto, Jonna M. E.
    Massey, Robert
    Mclennan, Niamh-Maire
    Miller, Rachel G.
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
  • [47] PREVALENCE OF ISLET-CELL AND THYROGASTRIC AUTOANTIBODIES IN SUDANESE PATIENTS WITH TYPE-1 DIABETES
    MAGZOUB, MMA
    ABDELHAMEED, AA
    BOTTAZZO, GF
    DIABETIC MEDICINE, 1994, 11 (02) : 188 - 192
  • [48] AUTOANTIBODIES PRESENT AT ONSET OF TYPE-1 DIABETES RECOGNIZE MULTIPLE ISLET CELL ANTIGENS
    KAROUNOS, DG
    NELL, LJ
    THOMAS, JW
    AUTOIMMUNITY, 1990, 6 (1-2) : 79 - 91
  • [49] Comparison of the Occurrence of Islet Autoantibodies in Siblings of Patients with Type 1 Diabetes Mellitus to Healthy Children
    Krzewska, Aleksandra
    Sieniawska, Joanna
    Ben-Skowronek, Iwona
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 228 - 228
  • [50] Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review
    Jamie L. Felton
    Maria J. Redondo
    Richard A. Oram
    Cate Speake
    S. Alice Long
    Suna Onengut-Gumuscu
    Stephen S. Rich
    Gabriela S. F. Monaco
    Arianna Harris-Kawano
    Dianna Perez
    Zeb Saeed
    Benjamin Hoag
    Rashmi Jain
    Carmella Evans-Molina
    Linda A. DiMeglio
    Heba M. Ismail
    Dana Dabelea
    Randi K. Johnson
    Marzhan Urazbayeva
    John M. Wentworth
    Kurt J. Griffin
    Emily K. Sims
    Communications Medicine, 4
12345